Varex Imaging (NASDAQ:VREX) Issues Q1 2025 Earnings Guidance

Varex Imaging (NASDAQ:VREX) updated its first quarter 2025 earnings guidance on Tuesday. The company provided earnings per share guidance of -0.050-0.100 for the period, compared to the consensus earnings per share estimate of 0.040. The company issued revenue guidance of $195.0 million-$215.0 million, compared to the consensus revenue estimate of $189.4 million. Varex Imaging also updated its Q1 guidance to $(0.05)-$0.10 EPS.

Varex Imaging Stock Up 3.1 %

Shares of VREX opened at $14.56 on Wednesday. The company has a quick ratio of 1.89, a current ratio of 3.34 and a debt-to-equity ratio of 0.67. The business has a fifty day moving average of $12.35 and a 200 day moving average of $13.46. The company has a market cap of $595.50 million, a PE ratio of 20.51 and a beta of 0.53. Varex Imaging has a 52-week low of $10.19 and a 52-week high of $21.50.

Wall Street Analysts Forecast Growth

Separately, B. Riley started coverage on shares of Varex Imaging in a research note on Friday, August 23rd. They issued a “buy” rating and a $21.00 target price on the stock.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.